Please join us on Thursday, June 16th at 5:00 pm EST (4:00 pm CST/2:00 pm PST) for a webinar about the HEALEY ALS Platform Trial. Sabrina Paganoni, MD, Ph.D., and Merit Cudkowicz, MD, MSc will present this week’s updates on the HEALEY ALS Platform Trial and answer questions from the audience. We will also be joined by guest speaker Bruce Rosenblum, a member of the Patient Advisory Committee for the Platform Trial’s Companion Expanded Access Program (EAP).
|
|
Bruce Rosenblum
Professionally, Bruce brings over 35 years of experience to his role as the Vice President of Content and Workflow solutions at Atypon Systems, where he has spent his career working to accelerate the speed of research publication. Bruce was diagnosed with ALS in 2017, and accelerating research became a personal matter. He has participated in multiple clinical trials and research studies, and he currently serves as a member of the Patient Advisory Committee for the Platform Trial’s companion Expanded Access Program (EAP). Bruce’s work as an ALS advocate centers on educating others about living with ALS and the opportunities that exist for patients to participate in ALS research.
|
|
|
